Weiling Pu

Dr. Weiling Pu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Phytomedicine
Verified
Journal Article
Closed access
HLHao Liu
Hao Liu
MHManru Huang
Manru Huang
DXDandan Xin
Dandan Xin
HWHong Wang
Hong Wang
HYHaiyang Yu
Haiyang Yu
WPWeiling Pu
Weiling Pu

24 October 2023 in Acupuncture and Herbal Medicine
Verified
Journal Article
Open access
LWLei Wang
Lei Wang
YXYingqiu Xie
Yingqiu Xie
SMSandugash Myrzagali
Sandugash Myrzagali
WPWeiling Pu
Weiling Pu
ELErwei Liu
Erwei Liu
Malignant tumor has become a major affecting human health, and is one of the main causes of human death. Recent studies have shown that many Traditional Chinese Medicines (TCM) have good antitumor activity, which may improve the therapeutic effect of routine treatment and quality of life with lower toxicity. However, the efficacy of TCM alone for the treatment of tumors is limited. Metal ions are essential substances for maintaining normal physiological activities. This paper summarized the multiple mechanisms that metal ions are involved in the prevention and treatment of tumors in TCM. Export

18 June 2024 in Cellular Signalling
Verified
Journal Article
Closed access
CLCaiyan Liu
Caiyan Liu
XHXiao Han
Xiao Han
SZSiqi Zhang
Siqi Zhang
MHManru Huang
Manru Huang
BGBin Guo
Bin Guo
HYHaiyang Yu
Haiyang Yu

4 March 2023 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
XHXiao Han
Xiao Han
JHJiayan Huang
Jiayan Huang
JLJia Lu
Jia Lu
FHFeng He
Feng He
FWFang Wang
Fang Wang
WPWeiling Pu
Weiling Pu

29 July 2022 in Research Square
Verified
Preprint
Open access
PDF file
XHXiao Han
Xiao Han
JHJiayan Huang
Jiayan Huang
JLJia Lu
Jia Lu
FHFeng He
Feng He
FWFang Wang
Fang Wang
WPWeiling Pu
Weiling Pu
Shuganning Injection (SGNI), a TCM (Traditional Chinese Medicine) injection with good hepato-protective effects, exerted therapeutic effects on HCC. However, the active compounds and effects of SGNI on hepatocellular carcinoma (HCC) remain unclear. To investigate the active compounds and potential targets of SGNI in the treatment of HCC, and explore the molecular mechanisms of main compounds. Network pharmacology was applied to predict the active compounds and targets of SGNI on cancer. The interaction between active compounds and target protein were validated by drug affinity responsive target stability (DARTS), cellular thermal shift assay (CETSA), and pull-down assay. The in vitro test of the effects and mechanism of vanillin and baicalein was elucidated by MTT, Western blot, immunofluorescence and apoptosis analysis. According to compound characteristics, targets, etc., two typical active ingredients (vanillin and baicalein) were selected as representatives to explore the effects on HCC. Vanillin (an important food additive), bound to NF-κB1 and baicalein (a bioactive flavonoid) bound to FLT3 (FMS-Like Tyrosine Kinase 3) were confirmed in this study. Vanillin and baicalein were both inhibited cell viability and promoted apoptosis of Hep3B and Huh7 cells. In addition, both vanillin and baicalein could enhance the activation of p38/MAPK (Mitogen-Activated Protein Kinase) signaling pathway, which may partially explain the anti-apoptosis effects of the two compounds. In conclusion, two active compounds of SGNI, baicalein and vanillin, promoted apoptosis of HCC cells via binding with NF-κB1 or FLT3, and regulating the p38/MAPK pathway. Baicalein and vanillin may be good candidates for HCC treatment on drug development.

23 June 2026 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
HZHuijie Zhang
Huijie Zhang
XZXiaoran Zhao
Xiaoran Zhao
FWFangyu Wang
Fangyu Wang
MLMeng Liu
Meng Liu
XQXiuping Qin
Xiuping Qin
WPWeiling Pu
Weiling Pu